跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Co-Altria - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Co-Altria
Approved
STANDARD
Co-Altria
Ajanta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bfba19bb1e579358
Company
Ajanta Pharma Limited
Type
Standard
Approval Details
Approval Id
bfba19bb1e579358
Drug Approval Philippines Name
Co-Altria
Product Name
Co-Altria
Registration Number
DRP-1822
Brand Name
Co-Altria
Generic Name
Montelukast (as sodium) + Levocetirizine hydrochloride
Dosage Form
Tablet
Dosage Strength
10mg/5mg
Manufacturer
Ajanta Pharma Limited
Importer
Ajanta Pharma Philippines Inc.
Company Detail Path
/organization/ajanta-pharma-limited
Issuance Date
28 May 2024
Expiry Date
21 July 2029
Pharmacologic Category
Leukotriene Receptor Antagonist/ Antihistamine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bfba19bb1e579358
Type
Standard
Back to Philippines FDA Approvals